Safety and immunogenicity of the Hendra virus recombinant soluble glycoprotein G Nipah virus vaccine in adults. Yadav PD, Sahay RR. Lancet 2025 Nov 14:S0140-6736(25)02277-9. doi: 10.1016/S0140-6736(25)02277.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yadav PD, Sahay RR. Safety and immunogenicity of the Hendra virus recombinant soluble glycoprotein G Nipah virus vaccine in adults. Lancet 2025 Nov 14:S0140-6736(25)02277-9. doi: 10.1016/S0140-6736(25)02277.
PMID: 41248668